Decorin: a possible marker for fetal growth restriction

References

• Illanes S, Soothill P. Management of fetal growth restriction. Semin Fetal Neonatal Med 2004;9:395–401
   PubMedGoogle Scholar
• Godfrey KM, Barker DJ. Fetal nutrition and adult disease. Am J Clin Nutr 2000;71:1344–52
   PubMed Web of Science ®Google Scholar
• Gagnon R. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol 2003;110:99–107
   PubMedGoogle Scholar
• Chang TC, Robson SC, Spencer JA, Gallivan S. Identification of fetal growth retardation: comparison of Doppler waveform indices and serial ultrasound measurements of abdominal circumference and fetal weight. Obstet Gynecol 1993;82:230–6
   PubMed Web of Science ®Google Scholar
• Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000;92:35–43
   PubMed Web of Science ®Google Scholar
• Lala PK, Hamilton GS. Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. Placenta 1996;17:545–55
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Castellucci M. Extravillous trophoblast in the human placenta. Troph Res 1997;10:21–65
   Google Scholar
• Chakraborty C, Gleeson LM, McKinnon T, Lala PK. Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol 2002;80:116–24
   PubMed Web of Science ®Google Scholar
• Lala PK, Chakraborty C. Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta 2003;24:575–87
   PubMed Web of Science ®Google Scholar
• Bauer S, Pollheimer J, Hartmann J, et al. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab 2004;89:812–22
   PubMed Web of Science ®Google Scholar
• Graham CH, Lala PK. Mechanism of control of trophoblast invasion in situ. J Cell Physiol 1991;148:228–34
   PubMed Web of Science ®Google Scholar
• Graham CH, Lysiak JJ, McCrae KR, Lala PK. Localization of transforming growth factor-beta at the human fetal–maternal interface: role in trophoblast growth and differentiation. Biol Reprod 1992;46:561–72
   PubMed Web of Science ®Google Scholar
• Graham CH, Hawley TS, Hawley RG, et al. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 1993;206:204–11
   PubMed Web of Science ®Google Scholar
• Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. Exp Cell Res 1995;217:419–27
   PubMed Web of Science ®Google Scholar
• Lysiak JJ, Hunt J, Pringle GA, Lala PK. Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta 1995;16:221–31
   PubMed Web of Science ®Google Scholar
• Xu G, Guimond MJ, Chakraborty C, Lala PK. Control of proliferation, migration, and invasiveness of human extravillous trophoblast by decorin, a decidual product. Biol Reprod 2002;67:681–9
   PubMed Web of Science ®Google Scholar
• Weber IT, Harrison RW, Iozzo RV. Model structure of decorin and implications for collagen fibrillogenesis. J Biol Chem 1996;271:31767–70
   PubMed Web of Science ®Google Scholar
• Torry DS, Hinrichs M, Torry RJ. Determinants of placental vascularity. Am J Reprod Immunol 2004;51:257–68
   PubMed Web of Science ®Google Scholar
• Arroyo JA, Winn VD. Vasculogenesis and angiogenesis in the IUGR placenta. Semin Perinatol 2008;32:172–7
   PubMed Web of Science ®Google Scholar
• Chen CP, Bajoria R, Aplin JD. Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. Am J Obstet Gynecol 2002;187:764–9
   PubMed Web of Science ®Google Scholar
• Lyall F, Young A, Boswell F, et al. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997;18:269–76
   PubMed Web of Science ®Google Scholar
• Khaliq A, Li XF, Shams M, et al. Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors 1996;13:243–50
   PubMed Web of Science ®Google Scholar
• Fairlie DP, West ML, Wong AK. Towards protein surface mimetics. Curr Med Chem 1998;5:29–62
   PubMed Web of Science ®Google Scholar
• Grant DS, Yenisey C, Rose RW, et al. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 2002;21:4765–77
   Google Scholar
• Neill T, Painter H, Buraschi S, et al. Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem 2012;287:5492–506
   PubMed Web of Science ®Google Scholar
• Iacob D, Cai J, Tsonis M, et al. Decorin-mediated inhibition of proliferation and migration of the human trophoblast via different tyrosine kinase receptors. Endocrinology 2008;149:6187–97
   PubMed Web of Science ®Google Scholar
• Swan BC, Murthi P, Rajaraman G, et al. Decorin expression is decreased in human idiopathic fetal growth restriction. Reprod Fertil Dev 2010;22:949–55
   PubMedGoogle Scholar
• Davies Cde L, Melder RJ, et al. Decorin inhibits endothelial migration and tubelike structure formation: role of thrombospondin-1. Microvasc Res 2001;62:26–42
   PubMedGoogle Scholar
• Gogiel T, Galewska Z, Romanowicz L, et al. Pre-eclampsia-associated alterations in decorin, biglycan and versican of the umbilical cord vein wall. Eur J Obstet Gynecol Reprod Biol 2007;134:51–6
   PubMedGoogle Scholar
• Gogiel T, Bańkowski E, Jaworski S. Pre-eclampsia-associated differential expression of proteoglycans in the umbilical cord arteries. Pathobiology 2001;69:212–18
   PubMed Web of Science ®Google Scholar